Comparison of Community-Associated and Health Care-Associated Methicillin-ResistantStaphylococcus aureusin Canada: Results from CANWARD 2007
Author(s) -
Kimberly A. Nichol,
Melissa McCracken,
Melanie DeCorby,
Kristjan Thompson,
Michael R. Mulvey,
James A. Karlowsky,
Daryl J. Hoban,
George G. Zhanel
Publication year - 2009
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 38
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/2009/853676
Subject(s) - methicillin resistant staphylococcus aureus , clindamycin , linezolid , medicine , tigecycline , microbiology and biotechnology , daptomycin , pulsed field gel electrophoresis , broth microdilution , vancomycin , trimethoprim , levofloxacin , moxifloxacin , staphylococcus aureus , antibiotics , minimum inhibitory concentration , biology , genotype , biochemistry , bacteria , gene , genetics
BACKGROUND: Community-associated methicillin-resistantStaphylococcus aureus (CA-MRSA) differ from health care-associatedMRSA (HA-MRSA) in their genotypic and phenotypic characteristics.The purpose of the present study was to compare the demographics,antimicrobial susceptibilities and molecular epidemiology ofCA-MRSA and HA-MRSA in Canada.METHODS: In 2007, 385 MRSA isolates were collected fromCanadian patients attending hospital clinics, emergency rooms, medical/surgical wards and intensive care units. Susceptibilities to betalactams,clarithromycin, clindamycin, daptomycin, levofloxacin,linezolid, moxifloxacin, tigecycline, trimethoprim-sulfamethoxazoleand vancomycin were determined by Clinical and LaboratoryStandards Institute broth microdilution. Strain typing was performedby pulsed-field gel electrophoresis (PFGE) and the mecA, nuc and pvlgenes were detected by polymerase chain reaction.RESULTS: Of the 385 MRSA, 19.5% were CA-MRSA and 79.2%were HA-MRSA as determined by PFGE. CA-MRSA belonged toPFGE types CMRSA10/USA300 (66.7%) and CMRSA7/USA400(33.3%); PFGE types identified among HA-MRSA includedCMRSA2/USA100/800 (81.6%), CMRSA6 (13.1%), CMRSA1/USA600 (3.3%), CMRSA5/USA500 (1.3%), CMRSA3 (0.3%) andCMRSA9 (0.3%). Panton-Valentine leukocidin (PVL) was detectedin 94.7% of CA-MRSA and 0.7% of HA-MRSA. Resistance rates(CA-MRSA versus HA-MRSA) were 61.3% versus 97.7% to levofloxacin,73.3% versus 96.7% to clarithromycin, 12.0% versus 74.8% toclindamycin and 0.0% versus 15.4% to trimethoprim-sulfamethoxazole.No MRSA were resistant to vancomycin, linezolid, tigecycline ordaptomycin.CONCLUSIONS: CA-MRSA represented 19.5% of all MRSA.CA-MRSA was significantly more susceptible to levofloxacin,clarithromycin, clindamycin and trimethoprim-sulfamethoxazole thanHA-MRSA. Of CA-MRSA, 94.7% were PVL-positive while 99.3% ofHA-MRSA were PVL-negative. CA-MRSA is an emerging pathogenin Canadian hospitals
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom